| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 158 |
| 1 | METHOTREXATE | 142 |
| 2 | RITUXIMAB | 107 |
| 3 | ADALIMUMAB | 94 |
| 4 | CYCLOPHOSPHAMIDE | 93 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 93 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 93 |
| 7 | MYCOPHENOLATE MOFETIL | 91 |
| 8 | PREDNISONE | 83 |
| 9 | ETANERCEPT | 75 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | 1 | 0.0081 |
| 2 | NELARABINE | 7 | 0.0072 |
| 3 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 4 | LISOCABTAGENE MARALEUCEL | 4 | 0.0046 |
| 5 | EPINEPHRINE HYDROCHLORIDE | 2 | 0.0042 |
| 6 | DALBAVANCIN HYDROCHLORIDE | 2 | 0.0042 |
| 7 | DACTINOMYCIN | 9 | 0.0041 |
| 8 | DELGOCITINIB | 1 | 0.0037 |
| 9 | DACARBAZINE | 24 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 245 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 153 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 145 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 143 |
| 4 | Alkylating Drug [EPC] | 107 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 105 |
| 6 | Platinum-based Drug [EPC] | 72 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 64 |
| 8 | Proton Pump Inhibitor [EPC] | 55 |
| 9 | Interferon beta [EPC] | 47 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 9 | 0.0041 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 3 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 16 | 0.0016 |
| 5 | Erythroid Maturation Agent [EPC] | 4 | 0.0015 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 15 | 0.0011 |
| 7 | Benzothiazole [EPC] | 2 | 0.0009 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 9 | CD30-directed Immunoconjugate [EPC] | 9 | 0.0009 |